ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Best Stocks To Buy Now: Wednesday, June 01, 2022

There are plenty of things that can surprise us every year. There are times when the stock market falls, and there are also times when the demand soars. The unpredictability of financial markets is what makes them exciting to follow. Even the best stock analysts and traders often have a hard time predicting what will happen in the coming year. But some analysts have shown an uncanny ability to predict what will happen in the stock market over five years.  Amazon stock forecast today is  $3,680, Tesla stock forecast today is $976.82, and PayPal stock forecast today is $124.27.

These analysts have identified stocks that will perform well over the next five years and have published their findings in various newsletters, services, and websites. These top predictions for 2022 range from artificial intelligence to biotechnology – see what are the best stocks to buy now that these experts recommend if you want to cash in on these trends over the next five years. Read on to learn more about these predictions and how they can affect your portfolio.

Cirrus Logic(NASDAQ: CRUS)

Cirrus Logic Stock
Source: Getty Images

When it comes to technology, few areas have the potential for growth as artificial intelligence. This trend could drive profits for Cirrus Logic (NASDAQ: CRUS), a company that develops AI-related hardware and software. The company specializes in chips that let computers quickly process and analyze large amounts of data. As AI grows in popularity, many companies will need chips like these to utilize computers and software fully. Many analysts expect this AI trend to boost Cirrus Logic’s profits by over 50% a year through 2022. If these predictions pass, CRUS stock could quickly rise to $150 a share or more by 2022. If you’re looking for a significant investment in artificial intelligence, CRUS stock is a great choice. 

The New York Times Company(NYSE: NYT)

The New York Times Company Stock
Source: Getty Images

When it comes to news, The New York Times (NYSE: NYT) is one of the most-read publications in the world. The company has also increased its digital presence in recent years. That has helped the company take advantage of the digital revolution and make more money through online ads. As a result, many analysts expect the company’s profits to soar in the coming years. By 2022, many experts believe that NYT stock could hit $35 or more a share. If these predictions come true, NYT stock would rise an astonishing 900% from its current price. If you’re looking for a stock that is likely to profit from the shift to digital media, consider buying NYT stock now. 

Atlassian (NASDAQ: TEAM)

Atlassian Stock
Source: Getty Images

Few companies have made as big a name for themselves as Atlassian (NASDAQ: TEAM) when it comes to business software. The company offers a wide range of products for project management, collaboration, and software development. As business software grows in popularity, many analysts expect Atlassian to grow with it. As a result, many experts believe that Atlassian’s profits will rise by over 50% a year through 2022. If these predictions come true, TEAM stock could easily hit $100 or more a share within the next five years. So if you’re looking for a company that will profit from the continued growth of business software, consider buying ATLN stock now.

Vertex Pharmaceuticals(NASDAQ: VRTX)

Vertex Pharmaceuticals Stock
Source: Getty Images

In the biotech industry, some of the best stocks to buy in 2022. This industry is expected to see significant growth as more people live longer and require medical care. Many biotech companies are working on new treatments for diseases, and Vertex Pharmaceuticals (NASDAQ: VRTX) is one of the best. The company is focused on developing new drugs that treat cystic fibrosis, hepatitis C, and inherited genetic diseases. Cystic fibrosis is a disease that causes mucus to build up throughout a person’s body. Vertex is developing a new drug to break down this mucus and treat the condition. If this drug is as successful as expected, VRTX stock could quickly rise above $200 a share in the next five years. If you’re looking for a biotech stock that is likely to profit from the growing need for medical care, consider buying VRTX stock. 

Conclusion

When it comes to investing, many things can affect the performance of your portfolio. There are times when the stock market soars, and there are also times when the market falls. Many trends will affect the performance of certain stocks. Some of these trends can significantly affect the performance of certain stocks. When you invest in stocks, it’s essential to follow these trends and the stocks affected by them. If you follow these trends and the stocks affected by them, you’ll have a better chance of making successful investments and growing your wealth

The post Best Stocks To Buy Now: Wednesday, June 01, 2022 appeared first on Best Stocks.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.